# Roberto Depascale

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/roberto-depascale/

## Facts

| Field | Value |
| --- | --- |
| Citations | 384 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 10 |
| i10-index | 11 |
| Last Known Institution | University of Padua |
| OpenAlex ID | https://openalex.org/A5028720421 |
| Works | 38 |

## Researcher papers

- [SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients](https://scholariq.org/papers/sars-cov-2-infection-in-patients-with-autoimmune-rheumatic-diseases-in-northeast/)
- [Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis](https://scholariq.org/papers/immunosuppressive-therapy-withdrawal-after-remission-achievement-in-patients/)
- [Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review](https://scholariq.org/papers/diagnosis-and-management-of-lung-involvement-in-systemic-lupus-erythematosus-and/)
- [Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)](https://scholariq.org/papers/early-and-late-response-and-glucocorticoid-sparing-effect-of-belimumab-in/)
- [Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis](https://scholariq.org/papers/effect-of-sustained-clinical-remission-on-the-risk-of-lupus-flares-and-impaired/)
- [Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support](https://scholariq.org/papers/modern-management-of-pregnancy-in-systemic-lupus-erythematosus-from-prenatal/)
- [Belimumab: a step forward in the treatment of systemic lupus erythematosus](https://scholariq.org/papers/belimumab-a-step-forward-in-the-treatment-of-systemic-lupus-erythematosus/)
- [When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?](https://scholariq.org/papers/when-should-targeted-therapies-be-used-in-the-treatment-of-lupus-nephritis-early/)
- [New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort](https://scholariq.org/papers/new-onset-and-flare-of-rheumatic-diseases-following-covid-19-vaccination-are/)
- [CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies](https://scholariq.org/papers/ccl18-as-a-biomarker-of-interstitial-lung-disease-ild-and-progressive-fibrosing/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [University of Padua](https://scholariq.org/institutions/university-of-padua/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.